Ibogaine access limited to eligible patients

Summary#

HB 4110, “Relating to ibogaine; prescribing an effective date,” would create rules for physician-provided ibogaine and amend Oregon’s controlled-substance definition in ORS 475.005. Its stated aim is to let eligible patients receive ibogaine to treat certain diagnosed disorders; it would not guarantee treatment or make ibogaine generally legal. The bill is listed as failed, so it did not change the law.

  • An attending physician could provide ibogaine for a patient’s consumption if the patient is at least 18, can make and communicate health care decisions in the physician’s opinion, and has one of the listed diagnoses: PTSD, major depressive disorder, anxiety disorder, or substance use disorder. The physician must judge that ibogaine may benefit the patient.
  • Consumption would have to occur in a controlled setting with a health care provider experienced in managing cardiac complications available on site. The setting must be created with consideration for the patient’s needs while experiencing ibogaine’s effects.
  • The Oregon Health Authority and Oregon Medical Board could adopt rules. The Medical Board could not discipline a physician for providing ibogaine in accordance with the bill.
  • Oregon’s controlled-substance definition would exclude ibogaine only to the extent it is obtained, provided, and consumed as the bill specifies. The bill would not exempt anyone from federal law or prevent federal enforcement.
  • If enacted, the provisions would become operative January 1, 2027. The bill is failed, so they are not in effect.

What it means for you#

  • Patients: The bill would not create a right to receive ibogaine. An attending physician could provide it only for a listed diagnosed disorder and only if the eligibility and setting conditions were met.
  • Physicians: A physician could choose to provide ibogaine under those conditions, and the Oregon Medical Board could not discipline the physician for doing so in accordance with the bill. The bill would not require a physician to offer it or protect anyone from federal law.
  • Oregon Health Authority and Oregon Medical Board: They could adopt rules, but the bill would not require them to do so.
  • General public: The bill would not broadly legalize ibogaine or change the controlled-substance treatment of use outside the specified conditions.

Money#

No cost information is in the available material.

  • The bill would allow the Oregon Health Authority and Oregon Medical Board to adopt rules and take preparatory actions, but no staffing or spending estimate is provided.
  • No publicly available information on costs to patients, physicians, or health care settings is provided.

What is unclear#

  • The bill does not set dosing, treatment, screening, monitoring, or follow-up rules.
  • It does not say who may supply ibogaine, how it must be obtained, or what standards apply to a “controlled setting.”
  • It does not define “health care provider” or explain how the required cardiac-care experience would be assessed.
  • It does not set a process for patient consent, physician decisions, oversight, complaints, or appeals.
  • The bill does not explain how its state-law exception would interact with federal law beyond saying it does not exempt anyone from or obstruct enforcement of federal law.

Case for#

  • A possible argument for the bill is that it would give physicians an option to consider for adults with specified disorders when, in the physician’s judgment, ibogaine may help.
  • The bill ties that option to a physician’s care responsibility and clinical judgment, rather than making ibogaine generally available.
  • Requiring an on-site provider experienced in managing cardiac complications could provide a safety measure during consumption.

Case against#

  • One concern is that the bill sets few treatment or oversight standards, leaving key safety details to rules that agencies may—but are not required to—adopt.
  • The bill requires a cardiac-experienced provider on site but does not define the provider’s qualifications or the setting’s other safety requirements.
  • It is unclear how the state-law exception would work in practice while federal law remains applicable.
  • The bill would protect physicians from Oregon Medical Board discipline only when they comply with its conditions; it does not explain how compliance would be assessed.